Adapt Pharma’s Nasal Spray Uses Unit-Dose Delivery System

Single-shot unit-dose system incorporates a primeless feature and 360-degree orientation to offer the patient or caregiver ready-to-use convenience.

Single-shot unit-dose system incorporates a primeless feature and 360-degree orientation to offer the patient or caregiver ready-to-use convenience.
Single-shot unit-dose system incorporates a primeless feature and 360-degree orientation to offer the patient or caregiver ready-to-use convenience.

Last November, the U.S. FDA approved Radnor, PA-based Adapt Pharma’s NARCAN® (naloxone hydrochloride) nasal spray for the emergency treatment of known or suspected opioid overdose.

Aptar Pharma recently announced that it provided the delivery system and regulatory support for Narcan, which it referred to as “the first U.S. FDA-approved nasally administered, needle-free, ready-to use medication that can stop or reverse the effects of an opioid overdose.”

The liquid spray drug delivery technology platform provides dose accuracy and ease of administration. The single-shot unit-dose system incorporates a primeless feature and 360-degree orientation to offer the patient or caregiver ready-to-use convenience.

List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
List: Digitalization Companies From PACK EXPO
Simplify robotics projects
Take control of your automation journey. Learn how to reduce risks and drive success in packaging robotics.
Read More
Simplify robotics projects